| #225 |
Carmen Bozic |
Biogen Ma |
1 |
| #225 |
William N. Haining |
Dana-Farber Cancer Institute |
1 |
| #225 |
Margo L. Ezekiel |
IBM |
1 |
| #225 |
John Stark |
Bio-Rad Laboratories |
1 |
| #225 |
David Arzumanyan |
Unknown |
1 |
| #225 |
Timothy Owen |
Datarobot |
1 |
| #225 |
Fernando G. Vieira |
Als Therapy Development Institute |
1 |
| #225 |
Ronald L. Walsworth |
Harvard University |
1 |
| #225 |
Jeffrey R. Jasperse |
Siemens Healthcare Diagnostics |
1 |
| #225 |
Doron Levari |
Ignite Scalarc Solutions |
1 |
| #225 |
David Wu |
Sharkninja Operating |
1 |
| #225 |
Daniel Elbaum |
Ra Pharmaceuticals |
1 |
| #225 |
Rachel Z. Pytel |
Certainteed |
1 |
| #225 |
Harvey Cohen |
Fresenius Medical Care Holdings |
1 |
| #225 |
Sebastian Schneeweiss |
— |
1 |
| #225 |
Nataly Kogan |
PayPal |
1 |
| #225 |
Mikhail Rubnich |
— |
1 |
| #225 |
Frances W. West |
IBM |
1 |
| #225 |
Michael Evan Kesselman |
Endurance International Group |
1 |
| #225 |
Joyce A. Sutcliffe |
Rib-X Pharmaceuticals |
1 |
| #225 |
Jyh-Yun John Wang |
— |
1 |
| #225 |
William Equitz |
Cognex |
1 |
| #225 |
Pablo G. Coste |
Arc Bio |
1 |
| #225 |
David Shadmon |
Emc |
1 |
| #225 |
Laurence S. Gillick |
Dragon Systems |
1 |
| #225 |
Michael E. Zalis |
The General Hospital |
1 |
| #225 |
Akintunde I. Akinwande |
MIT |
1 |
| #225 |
Reshmi Mukherjee |
Polyphor Ag |
1 |
| #225 |
Thomas F. Quatieri, Jr. |
MIT |
1 |
| #225 |
Jian Wang |
Vertex Pharmaceuticals Incorporated |
1 |
| #225 |
Richard J. Morris |
Diversi Plast Products |
1 |
| #225 |
Robert D. Arbeit |
X4 Pharmaceuticals |
1 |
| #225 |
Matthew L. Sherman |
Acceleron Pharma |
1 |
| #225 |
Stella Kourembanas |
Children'S Medical Center |
1 |
| #225 |
Anna I. Mandinova |
The General Hospital |
1 |
| #225 |
Sachet Ashok Shukla |
Dana-Farber Cancer Institute |
1 |
| #225 |
Zhihong Zhao |
The Mathworks |
1 |
| #225 |
Evan Costa |
Interscope |
1 |
| #225 |
Ezra S. Abrams |
Sage Science |
1 |
| #225 |
Raymond Comenzo |
Tufts Medical Center |
1 |
| #225 |
Jana Von Hehn |
Concert Pharmaceuticals |
1 |
| #225 |
Michael Steven Vincent |
Pfizer |
1 |
| #225 |
Dennis Waldman |
Cognatus Innovations |
1 |
| #225 |
Hsiao-Ming Lu |
The General Hospital |
1 |
| #225 |
Boshan Mo |
— |
1 |
| #225 |
Guiqing Huang |
— |
1 |
| #225 |
James M. Kramer |
Cereal Enterprises |
1 |
| #225 |
Rhoda Myra Alani |
The Johns Hopkins University |
1 |
| #225 |
David Parmenter |
Adobe |
1 |
| #225 |
Grant Thomas-Lepore |
Stratasys |
1 |